A hearing will get underway in Delaware later today in the latest phase of GSK’s attempts to defend itself from allegations that its Zantac drug caused cancer in patients. The three-day hearing ...
A spokesperson told pharmaphorum that from now onwards the programme will cover just 12 countries, namely: Colombia, India, Indonesia, Malaysia, Mexico, New Zealand, Philippines, Serbia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback